InfuSystem (NYSE:INFU) Stock Price Down 1.3% - Time to Sell?

Key Points

• INFU fell 1.3% to $10.27 on Thursday with volume down about 38% versus its average daily trading, and it trades above its 50- and 200-day simple moving averages (~$9.32 and $9.20).
• Analysts have a consensus "Buy" rating and a $15.00 consensus target price, with Roth MKM recently reiterating a buy and raising its target to $15.00.
• InfuSystem is a medical-technology firm that rents and services infusion pumps and is expanding into remote patient monitoring; it has a market cap of ~$207M, a high PE (~171), and roughly 71% institutional ownership.

InfuSystem Holdings, Inc. (NYSE:INFU - Get Free Report) was down 1.3% during trading on Thursday . The stock traded as low as $10.22 and last traded at $10.27. Approximately 75,645 shares traded hands during trading, a decline of 38% from the average daily volume of 122,904 shares. The stock had previously closed at $10.41.

Analyst Ratings Changes

Separately, Roth Mkm reissued a "buy" rating and issued a $15.00 target price (up from $14.00) on shares of InfuSystem in a research note on Tuesday, February 24th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of "Buy" and a consensus target price of $15.00.

InfuSystem Stock Down 1.3%

The firm has a market cap of $207.39 million, a PE ratio of 171.20 and a beta of 1.54. The company has a 50-day simple moving average of $9.32 and a 200-day simple moving average of $9.20. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.98 and a quick ratio of 1.59.

Hedge Funds Weigh In On InfuSystem

Several hedge funds have recently bought and sold shares of INFU. North Star Investment Management Corp. increased its stake in InfuSystem by 527.6% in the first quarter. North Star Investment Management Corp. now owns 182,000 shares of the company's stock worth $1,680,000 after purchasing an additional 153,000 shares during the period. Ritholtz Wealth Management boosted its stake in shares of InfuSystem by 104.9% during the first quarter. Ritholtz Wealth Management now owns 35,870 shares of the company's stock valued at $331,000 after purchasing an additional 18,362 shares during the period. Hsbc Holdings PLC boosted its stake in shares of InfuSystem by 10.7% during the fourth quarter. Hsbc Holdings PLC now owns 28,478 shares of the company's stock valued at $255,000 after purchasing an additional 2,763 shares during the period. Aristides Capital LLC purchased a new stake in shares of InfuSystem during the fourth quarter valued at $110,000. Finally, Virtu Financial LLC bought a new position in shares of InfuSystem in the fourth quarter worth about $90,000. Institutional investors own 71.13% of the company's stock.

InfuSystem Company Profile

InfuSystem Holdings Inc is a medical technology company that specializes in the rental, management and servicing of infusion pumps and associated devices used primarily for outpatient infusion therapy. The company provides a comprehensive suite of services that includes equipment delivery, setup and retrieval, preventive and corrective maintenance, reprocessing and quality assurance. InfuSystem's offerings are designed to help hospitals, ambulatory surgery centers, oncology clinics and private infusion suites streamline clinical operations and maintain compliance with safety standards.

In addition to pump rental and repair services, InfuSystem has expanded into remote patient monitoring solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.